{"slideshow_credits": null, "snippet": "The hedge fund billionaire William A. Ackman sent a letter to the board of the Botox manufacturer Allergan on Monday, urging the company to begin talks to sell itself to Valeant.", "abstract": "The hedge fund billionaire William A. Ackman sent a letter to the board of the Botox manufacturer Allergan on Monday, urging the company to begin talks to sell itself to Valeant.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "DE LA MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. DE LA MERCED"}, "web_url": "http://dealbook.nytimes.com/2014/05/05/ackman-urges-allergan-board-to-begin-deal-talks-with-valeant/", "lead_paragraph": null, "headline": {"main": "Ackman Urges Allergan Board to Begin Deal Talks With Valeant", "kicker": "DealBook"}, "_id": "5367db7138f0d8698e5e0673", "word_count": "349", "multimedia": [{"height": 126, "url": "images/2014/05/06/business/dbpix-botox1/dbpix-botox1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/05/06/business/dbpix-botox1/dbpix-botox1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 821, "url": "images/2014/05/06/business/dbpix-botox1/dbpix-botox1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/05/06/business/dbpix-botox1/dbpix-botox1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "821"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/05/06/business/dbpix-botox1/dbpix-botox1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/05/06/business/dbpix-botox1/dbpix-botox1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-05-05T14:40:42Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Ackman, William A", "rank": "1"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": "2"}, {"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "subject", "value": "Shareholder Rights and Activism", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}